Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

Plans to launch its PrefGel in the third quarter of 1998 following recent FDA clearance, the company says June 3. PrefGel, which is to be used by periodontists for conditioning exposed root surfaces during periodontal surgery, received European approval under the name PrepHgel earlier this year. PrefGel is the company's second dental therapy to reach the market. Its first product, Emdogain, for treatment of intrabony defects, was approved in 1996 ("The Gray Sheet" Oct. 21, 1996, I&W-4)...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts